Loading…

Clinical performance of two ion‐releasing bulk‐fill composites in class I and class II restorations: A two‐year evaluation

Objectives This randomized clinical trial evaluated and compared the 2‐year clinical performance of two ion‐releasing bulk‐fill composites (Cention N and Surefil One) with that of a conventional bulk‐fill resin composite (Powerfil) in Class I and II cavities. Methods Thirty‐two patients, each with 3...

Full description

Saved in:
Bibliographic Details
Published in:Journal of esthetic and restorative dentistry 2024-05, Vol.36 (5), p.723-736
Main Authors: Albelasy, Eman H., Hamama, Hamdi H., Chew, Hooi Pin, Montasser, Marmar, Mahmoud, Salah H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives This randomized clinical trial evaluated and compared the 2‐year clinical performance of two ion‐releasing bulk‐fill composites (Cention N and Surefil One) with that of a conventional bulk‐fill resin composite (Powerfil) in Class I and II cavities. Methods Thirty‐two patients, each with 3 Class I and/or Class II cavities under occlusion, were enrolled in this trial. A total of 96 restorations were placed, 32 for each material, as follows: a self‐adhesive composite; Surefil‐one, alkasite; Cention N, and a bulk‐fill resin composite; Powerfil. The restorations were placed by a single operator. Clinical evaluation was performed at baseline (1‐week), 6‐months, 1‐year, and 2‐years by two independent examiners using the FDI criteria. Intergroup and intragroup comparisons were analyzed using the Kruskal–Wallis and Friedman Tests. Multiple comparisons between groups were analyzed using the Mann–Whitney and Wilcoxon‐rank tests. The level of significance was set at α = 0.05. Results Twenty‐seven patients with a total of 81 restorations were evaluated at the end of the 2‐years with 84.35% recall rates. Clinical success rates were 100%, 100%, and 96.3% for Powerfil, Surefil‐one, and Cention N, respectively. Cention N showed a statistically significant (p 
ISSN:1496-4155
1708-8240
DOI:10.1111/jerd.13193